Do we need placebo control in maintenance studies in bipolar disorders?

Bipolar Disorders

Volumn 4, Issue SUPPL. 1, 2002, Pages 61-

  Vieta, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; NEW DRUG; PLACEBO;

AFFECTIVE NEUROSIS; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INFORMED CONSENT; LICENCE; MAINTENANCE THERAPY; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL DECISION MAKING; MEDICAL ETHICS; METHODOLOGY; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

BIPOLAR DISORDER; CONTROLLED CLINICAL TRIALS; HUMANS; INFORMED CONSENT; PLACEBOS; TREATMENT OUTCOME;

EID: 0036385319     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2002.01180.x     Document Type: Article

References (3)

1. Keck PE Jr, Welge JA, Strawoski SM, Arnold LM, McElroy SL. Placebo effect in randomized, controlled maintenance studies of patients with bipolar disorder. Biol Psychiatry 2000; 47: 756-761.
2. Charney DS, Nemeroff CB, Lewis L et al. National depressive and manic-depressive association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry 2002; 59: 262-270.
3. Post RM, Denicoff KD, Leverich GS. Special issues in trial design and use of placebo in bipolar illness. Biol Psychiatry 2000; 47: 727-732.